In the final part of this roundtable discussion, a panel of subject matter experts discuss what the future holds for this technology, why end-to-end visibility is necessary in healthcare, and the ...

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the ...

A session investigates the drivers of these shortages and ways to mitigate them. Another session along Trade & Channel Strategies’ supply chain, distribution, and logistics track focused on “Actions ...

Trade & Channel Strategies carried on, with a case study on how to “Navigate Pharmacy and Distribution Models for Market Access Mastery.” John Harlow, chief commercial officer at Melinta Therapeutics, ...

Our December analysis of the twists and turns in the Drug Supply Chain Security Act is a timely one, as the FDA recently again pushed back the deadline for complying with new mandates on tracking and ...

This year’s Trade & Channel Strategies Conference in Philadelphia kicked off with a keynote address from Bill Roth, SVP of IntegriChain’s consulting business, Blue Fin Group, and Pharma Commerce board ...

The value of this sometimes-unheralded technology to the pharma industry—as well as potential use cases—are starting to come to light. As I pondered what the angle of this month’s editor's column ...

Day 1 of Trade & Channel Strategies in Philadelphia welcomed several captivating sessions, including a panel centered around “Pharmacy Evolved—Aligning Commercialization to the Changing Pharmacy ...

Access Insights Conference delves into the latest obstacles, while mapping out potential solutions to address them. The commercial, financial, and operational teams that represent pharmaceutical ...

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.